EX-99..1 2 fy19_q3xex-991.htm EXHIBIT 99..1 Exhibit


Exhibit 99.1

Helen of Troy Limited Reports Third Quarter Fiscal 2019 Results

Consolidated Net Sales Revenue Growth of 2.4%; Core Business Growth of 2.9%
GAAP Diluted Earnings Per Share ("EPS") from Continuing Operations of $2.06
Adjusted Diluted EPS from Continuing Operations of $2.40
Updates Fiscal 2019 Diluted EPS from Continuing Operations Outlook to $6.35 - $6.51
Updates Fiscal 2019 Adjusted Diluted EPS from Continuing Operations Outlook to $7.70 - $7.95
Updates Fiscal 2019 Consolidated Net Sales Outlook to $1.535 - $1.550 billion

El Paso, Texas, January 8, 2019 — Helen of Troy Limited (NASDAQ: HELE), designer, developer and worldwide marketer of consumer brand-name housewares, health and home and beauty products, today reported results for the three-month period ended November 30, 2018. Following the divestiture of Healthy Directions on December 20, 2017, the Company no longer consolidates the Nutritional Supplements segment’s operating results. That former segment’s operating results are included in the Company’s financial statements and classified as discontinued operations for all periods presented.  
 
Executive Summary – Third Quarter of Fiscal 2019

Consolidated net sales revenue increase of 2.4%, including:
An increase in Leadership Brand net sales of approximately 4.9%
An increase in online channel net sales of approximately 6.0%
Core business growth of 2.9%

GAAP operating income of $61.3 million, or 14.2% of net sales, compared to $67.3 million, or 16.0% of net sales, for the same period last year, which included pre-tax restructuring charges of $1.2 million

Non-GAAP adjusted operating income decline of 8.9% to $70.6 million, or 16.4% of net sales, compared to $77.6 million, or 18.4% of net sales, for the same period last year

GAAP diluted EPS from continuing operations of $2.06, compared to $2.15 for the same period last year, which included a restructuring charge of $0.04 per share

Non-GAAP adjusted diluted EPS from continuing operations decline of 4.0% to $2.40, compared to $2.50 for the same period last year

Repurchased 813,696 shares of common stock in the open market during the quarter for $100.0 million, or an average price of $122.90 per share

Julien R. Mininberg, Chief Executive Officer, stated: “The Company’s third quarter performance was in line with our expectations, bringing our year to date results to 8.1% net sales growth and 12.4% adjusted diluted EPS growth. Investment in our Leadership Brands continued to drive top line momentum in the quarter, growing their net sales 4.9%. The Company’s total online sales increased by 6.0%, representing 18.0% of our total net sales for the quarter. Net sales in our Housewares segment grew double digits, propelled by point of sale growth, incremental domestic distribution, higher online sales, and incremental sales from new product introductions. Our Health & Home segment faced a tough comparison to the strong third quarter of last fiscal year, compounded by a slowdown in China ecommerce and foreign exchange headwinds. Our Beauty segment continues to focus on appliances, which benefited from new product introductions and online growth.”


1



Mr. Mininberg continued: "Our adjusted operating margin for the quarter primarily reflects our strategic choices to increase incremental digital marketing spend and new product introductions for our Leadership Brands. As expected, this quarter, we also started to feel the impact of tariffs ahead of the pricing actions we began implementing in the third quarter and which will largely take effect over the next two quarters. Retailers and consumers are just now beginning to digest higher prices, which could affect short-term shipments and consumption. We believe, however, that our pricing choices are right for the long-term health of the business."

Mr. Mininberg concluded: "As we look to fiscal 2020, which begins this March, we have made our strategic choices for a second phase of Helen of Troy’s transformation. This next phase is designed to build on the successes of the past five years. We will focus on driving further improvements to our current businesses, our geographic footprint, our global shared services, and the overall strength of our organization. We will also seek to add to our Leadership Brand portfolio through acquisition. We believe we have the balance sheet, the capabilities, the culture, and the passionate, owner-minded people to take our transformation to the next level. We look forward to sharing more during our next investor day, which is currently planned for late Spring."
 
Three Months Ended November 30,
 
Housewares
 
Health & Home
 
Beauty
 
Total
Fiscal 2018 sales revenue, net
$
128,261

 
$
189,240

 
$
103,340

 
$
420,841

Core business growth (decline)
14,828

 
(313
)
 
(2,458
)
 
12,057

Impact of foreign currency
(152
)
 
(1,064
)
 
(601
)
 
(1,817
)
Change in sales revenue, net
14,676


(1,377
)

(3,059
)

10,240

Fiscal 2019 sales revenue, net
$
142,937

 
$
187,863

 
$
100,281

 
$
431,081

 
 
 
 
 
 
 
 
Total net sales revenue growth (decline)
11.4
 %
 
(0.7
)%
 
(3.0
)%
 
2.4
 %
Core business growth (decline)
11.6
 %
 
(0.2
)%
 
(2.4
)%
 
2.9
 %
Impact of foreign currency
(0.1
)%
 
(0.6
)%
 
(0.6
)%
 
(0.4
)%
 
 
 
 
 
 
 
 
Operating margin (GAAP)
 
 
 
 
 
 
 
Fiscal 2019
20.9
 %
 
10.2
 %
 
12.2
 %
 
14.2
 %
Fiscal 2018
23.2
 %
 
14.6
 %
 
9.6
 %
 
16.0
 %
Adjusted operating margin (non-GAAP)
 
 
 
 
 
 
 
Fiscal 2019
22.8
 %
 
13.0
 %
 
13.5
 %
 
16.4
 %
Fiscal 2018
24.7
 %
 
17.0
 %
 
13.3
 %
 
18.4
 %

Consolidated Operating Results - Third Quarter Fiscal 2019 Compared to Third Quarter Fiscal 2018

Consolidated net sales revenue increased 2.4% to $431.1 million compared to $420.8 million, primarily driven by a core business increase of $12.1 million, or 2.9%, reflecting an increase in brick and mortar sales in our Housewares segment and growth in consolidated online sales.
Net sales from Leadership Brands increased 4.9% to $343.4 million, compared to $327.3 million. These factors were partially offset by a decline in the personal care category and the discontinuation of certain brands and products in the Beauty segment, a deceleration of growth in China ecommerce, and the unfavorable impact from foreign currency fluctuations of approximately $1.8 million, or 0.4%. The Company reclassified $2.9 million of expense from selling, general and administrative expense ("SG&A") to a reduction of net sales revenue for the third quarter of fiscal 2018 to conform with ASU 2014-09 “Revenue from Contracts with Customers”. Please refer to Note 9 of the accompanying schedules to the press release for additional information.

Consolidated gross profit margin decreased 0.1 percentage point to 42.2%, compared to 42.3%. The decrease is primarily due to less favorable product mix and the impact of tariff increases, partially offset by the favorable margin impact from growth in our Leadership Brands.

2




Consolidated SG&A as a percentage of sales increased by 1.9 percentage points to 28.0% of net sales compared to 26.1%. The increase is primarily due to higher advertising expense, increased freight costs, increased share-based compensation expense and higher product claim expense. These factors were partially offset by the favorable comparative impact of foreign currency exchange and forward contract settlements, the favorable comparative impact of restructuring charges in the same period last year and lower amortization expense.

Consolidated operating income was $61.3 million, or 14.2% of net sales, compared to $67.3 million, or 16.0% of net sales. The decrease in consolidated operating margin primarily reflects higher advertising expense, the impact of tariff increases, higher freight expense and increased share-based compensation expense. These factors were partially offset by the favorable comparative impact of foreign currency exchange and forward contract settlements, the net favorable comparative impact of restructuring charges of $1.1 million, lower amortization expense and the favorable margin impact from Leadership Brand growth.

The effective tax rate was 6.9%, compared to 8.2% for the same period last year. The year-over-year decline in the effective tax rate is primarily due to shifts in the mix of taxable income in our various tax jurisdictions.    

Income from continuing operations was $54.3 million, or $2.06 per diluted share on 26.4 million weighted average shares outstanding, compared to $58.6 million, or $2.15 per diluted share on 27.3 million weighted average diluted shares outstanding. Income from continuing operations for the third quarter of fiscal 2019 includes an insignificant amount of after-tax restructuring charges, compared to $0.04 per share in the same prior year period.

Loss from discontinued operations was $4.9 million, or $0.18 per diluted share, compared to a loss of $89.1 million, or $3.27 per diluted share, for the same period last year.

Adjusted EBITDA (EBITDA excluding restructuring charges, the Toys "R" Us ("TRU") bankruptcy charge, non-cash asset impairment charges, and non-cash share based compensation, as applicable) decreased 8.3% to $74.5 million compared to $81.3 million.

On an adjusted basis for the third quarters of fiscal 2019 and 2018, excluding restructuring charges, the TRU bankruptcy charge, non-cash asset impairment charges, noncash share-based compensation, and non-cash amortization of intangible assets, as applicable:

Adjusted operating income decreased $6.9 million, or 8.9%, to $70.6 million, or 16.4% of net sales, compared to $77.6 million, or 18.4% of net sales. The 2.0 percentage point decrease in adjusted operating margin primarily reflects higher advertising expense, the impact of tariff increases, higher freight expense and increased share-based compensation expense. These factors were partially offset by the favorable comparative impact of foreign currency exchange and forward contract settlements, lower amortization expense and the favorable margin impact from Leadership Brand growth.

Adjusted income from continuing operations decreased $4.9 million, or 7.1%, to $63.2 million, or $2.40 per diluted share, compared to $68.1 million, or $2.50 per diluted share. The 4.0% decrease in adjusted diluted EPS from continuing operations was primarily due to lower operating income from the Health & Home segment, partially offset by higher adjusted operating income from the Housewares segment, lower interest expense, lower tax expense, and the impact of lower weighted average diluted shares outstanding.



3



Segment Operating Results - Third Quarter Fiscal 2019 Compared to Third Quarter Fiscal 2018
Housewares net sales increased by 11.4%, or $14.7 million, due to point of sale growth and incremental distribution with existing domestic brick and mortar customers, an increase in overall online sales, and new product introductions. These factors were partially offset by lower club channel sales and a reduction in inventory by a key online retailer. Operating margin was 20.9% compared to 23.2%. The 2.3 percentage point decrease was primarily due to higher advertising expense, higher annual incentive compensation expense related to strong current year performance, higher freight expense, and higher rent expense related to previously-announced new office space. These factors were partially offset by the margin impact of more favorable product and channel mix and the favorable impact of increased operating leverage from net sales growth. Housewares adjusted operating income increased 2.7% to $32.6 million, or 22.8% of segment net sales, compared to $31.7 million, or 24.7% of segment net sales.  
Health & Home net sales decreased 0.7%, primarily due to the unfavorable impact of net foreign currency fluctuations of $1.1 million, or 0.6%, and a core business decline of $0.3 million, or 0.2%. The core business decline primarily reflects lower online sales and the unfavorable comparative impact from international distribution gains in the prior year period. This was compounded by a deceleration of growth in China ecommerce and a corresponding buildup of inventory in the channel. These factors were partially offset by incremental distribution and shelf space gains with existing domestic customers and strong seasonal category growth. Operating margin was 10.2% compared to 14.6%. The decrease was primarily due to higher advertising expense, increased promotional spending and trade support with retail customers, tariff increases, a less favorable product and channel mix, and higher personnel expense. These factors were partially offset by the favorable comparative impact of foreign currency exchange and forward contract settlements. Health & Home adjusted operating income decreased 23.7% to $24.5 million, or 13.0% of segment net sales, compared to $32.1 million, or 17.0% of segment net sales.

Beauty net sales decreased 3.0%, or $2.5 million, reflecting a decrease in brick and mortar sales, a decline in the personal care category and the discontinuation of certain brands and products. These factors more than offset growth in the online channel, an increase in international sales, and new product introductions in the retail appliance category.  Segment net sales were unfavorably impacted by net foreign currency fluctuations of approximately $0.6 million, or 0.6%. Operating margin was 12.2% compared to 9.6%. The increase is primarily due to the net favorable comparative impact of pre-tax restructuring charges of $1.1 million year-over-year, lower amortization expense, and personnel cost savings from our restructuring plan, referred to as Project Refuel. These factors were partially offset by higher advertising expense and higher freight expense. Beauty adjusted operating income decreased 1.2% to $13.6 million, or 13.5% of segment net sales, compared to $13.7 million, or 13.3% of segment net sales.

Balance Sheet and Cash Flow Highlights - Third Quarter Fiscal 2019 Compared to Third Quarter Fiscal 2018

Cash and cash equivalents totaled $19.1 million, compared to $19.9 million

Total short- and long-term debt was $339.7 million, compared to $426.2 million, a net decrease of $86.5 million

Accounts receivable turnover was 69.4 days, compared to 65.4 days

Inventory was $300.6 million, compared to $278.1 million. Inventory turnover was 3.4 times compared to 2.8 times.

Net cash provided by operating activities from continuing operations for the first nine months of the fiscal year increased $6.6 million to $109.5 million. The increase was primarily due to an increase in income from continuing operations, higher share-based compensation and an

4



increase in cash provided from accounts payable. These factors were partially offset by an increase in cash used for inventory and a dispute settlement payment of $15.0 million.    

Fiscal 2019 Annual Outlook
For fiscal 2019, the Company is updating its outlook for consolidated net sales revenue to be in the range of $1.535 to $1.550 billion, which implies consolidated sales growth of 3.8% to 4.8% after accounting for the expected impact from the adoption of ASU 2014-09 “Revenue from Contracts with Customers” (Revenue Recognition Standard) in fiscal 2019 with conforming reclassifications to fiscal 2018.  Please refer to the table entitled “Fiscal Year 2019 Outlook for Net Sales Revenue After Adoption of Revenue Recognition Standard” in the accompanying tables to this press release for additional information. 

The Company's sales outlook now includes the following items, which together account for the $10 million reduction to the high end of the range and primarily impact the Health & Home segment:
An expected unfavorable impact from pricing actions that have not been resolved with a key customer in two of our product categories; and
A deceleration of growth in China ecommerce, with corresponding high inventory levels in the channel for one of our product categories and the impact that we believe trade tensions are having on both the U.S. and Chinese consumers.

The Company’s net sales outlook continues to assume the severity of the cough/cold/flu season will be in line with historical averages, which unfavorably impacts the year-over-year comparison by 1.1%. The Company’s net sales outlook also assumes that December 2018 foreign currency exchange rates will remain constant for the remainder of the fiscal year.

Finally, the Company’s net sales outlook now reflects the following expectations by segment:
Housewares net sales growth of 11% to 13% compared to the prior expectation of 9% to 11%;
Health & Home net sales growth of 2% to 4%, including an unfavorable impact of approximately 2.3% from the average cough/cold/flu season assumption, compared to the prior expectation of 5% to 7%; and
Beauty net sales decline in the low- to mid-single digits, which remains the same.

Despite the decline in the high end of our net sales outlook range, we are increasing our GAAP diluted and Non-GAAP adjusted diluted EPS outlook to reflect the lower share count from open market repurchases made during the third quarter. The Company now expects consolidated GAAP diluted EPS from continuing operations of $6.35 to $6.51, and non-GAAP adjusted diluted EPS from continuing operations in the range of $7.70 to $7.95, which excludes any asset impairment charges, restructuring charges, share-based compensation expense and intangible asset amortization expense. The Company continues to expect the year-over-year comparison of adjusted diluted EPS from continuing operations to be impacted by an expected increase in growth investments in support of the Company’s Leadership Brands of 18% to 22% in fiscal 2019.

The Company’s diluted EPS from continuing operations outlook assumes that December 2018 foreign currency exchange rates will remain constant for the remainder of the fiscal year. The diluted earnings per share outlook is now based on an updated estimated weighted average diluted shares outstanding of 26.0 million for the fourth quarter of fiscal 2019, reflecting the impact of open market share repurchases made in the third quarter of fiscal 2019.

As previously announced, the Company has initiated Project Refuel, which continues to target annualized profit improvement of approximately $8.0 million to $10.0 million over the duration of the plan. The plan is estimated to be completed by the first quarter of fiscal 2020, and the Company expects to incur total cumulative restructuring charges in the range of $5.0 million to $5.5 million over the period of the plan.

5




The Company now expects a reported GAAP effective tax rate range of 7.3% to 8.4%, and an adjusted effective tax rate range of 6.9% to 7.7% for the full fiscal year 2019.  Please refer to the schedule entitled “Effective Tax Rate (GAAP) and Adjusted Effective Tax Rate (Non-GAAP)” in the accompanying tables to this press release.

The likelihood and potential impact of any fiscal 2019 acquisitions and divestitures, future asset impairment charges, future foreign currency fluctuations, or further share repurchases are unknown and cannot be reasonably estimated; therefore, they are not included in the Company’s sales and earnings outlook.

Conference Call and Webcast
The Company will conduct a teleconference in conjunction with today’s earnings release. The teleconference begins at 9:00 a.m. Eastern Time today, Tuesday, January 8, 2019. Investors and analysts interested in participating in the call are invited to dial (800) 458-4121 approximately ten minutes prior to the start of the call. The conference call will also be webcast live at:  http://investor.hotus.com/. A telephone replay of this call will be available at 12:00 p.m. Eastern Time on January 8, 2019 until 11:59 p.m. Eastern Time on January 15, 2019 and can be accessed by dialing (844) 512-2921 and entering replay pin number 3806938. A replay of the webcast will remain available on the website for one year.

Non-GAAP Financial Measures
The Company reports and discusses its operating results using financial measures consistent with accounting principles generally accepted in the United States of America (“GAAP”). To supplement its presentation, the Company discloses certain financial measures that may be considered non-GAAP financial measures, such as Leadership Brand net sales, adjusted operating income, adjusted operating margin, adjusted effective tax rate, adjusted income, adjusted diluted earnings per share, EBITDA and adjusted EBITDA, which are presented in accompanying tables to this press release along with a reconciliation of these financial measures to their corresponding GAAP-based measures presented in the Company’s condensed consolidated statements of income. All references to our continuing operations exclude the Nutritional Supplements segment.

About Helen of Troy Limited
Helen of Troy Limited (NASDAQ: HELE) is a leading global consumer products company offering creative solutions for its customers through a strong portfolio of well-recognized and widely-trusted brands, including OXO, Hydro Flask, Vicks, Braun, Honeywell, PUR, and Hot Tools. All trademarks herein belong to Helen of Troy Limited (or its affiliates) and/or are used under license from their respective licensors.

For more information about Helen of Troy, please visit http://investor.hotus.com/

Forward Looking Statements
Certain written and oral statements made by our Company and subsidiaries of our Company may constitute “forward-looking statements” as defined under the Private Securities Litigation Reform Act of 1995. This includes statements made in this press release. Generally, the words “anticipates”, “believes”, “expects”, “plans”, “may”, “will”, “should”, “seeks”, “estimates”, “project”, “predict”, “potential”, “continue”, “intends”, and other similar words identify forward-looking statements. All statements that address operating results, events or developments that we expect or anticipate will occur in the future, including statements related to sales, earnings per share results, and statements expressing general expectations about future operating results, are forward-looking statements and are based upon our current expectations and various assumptions. We believe there is a reasonable basis for our expectations and assumptions, but there can be no assurance that we will realize our expectations or that our assumptions will prove correct. Forward-looking statements are subject to risks that could cause them to differ

6



materially from actual results. Accordingly, we caution readers not to place undue reliance on forward-looking statements. The forward-looking statements contained in this press release should be read in conjunction with, and are subject to and qualified by, the risks described in the Company’s Form 10-K for the year ended February 28, 2018, and in our other filings with the SEC. Investors are urged to refer to the risk factors referred to above for a description of these risks. Such risks include, among others, our ability to deliver products to our customers in a timely manner and according to their fulfillment standards, the costs of complying with the business demands and requirements of large sophisticated customers, our relationships with key customers and licensors, our dependence on the strength of retail economies and vulnerabilities to any prolonged economic downturn, our dependence on sales to several large customers and the risks associated with any loss or substantial decline in sales to top customers, expectations regarding any proposed restructurings, our recent and future acquisitions or divestitures, including our ability to realize anticipated cost savings, synergies and other benefits along with our ability to effectively integrate acquired businesses or separate divested businesses, circumstances which may contribute to future impairment of goodwill, intangible or other long-lived assets, the retention and recruitment of key personnel, foreign currency exchange rate fluctuations, disruptions in U.S., U.K., Eurozone, and other international credit markets, risks associated with weather conditions, the duration and severity of the cold and flu season and other related factors, our dependence on foreign sources of supply and foreign manufacturing, and associated operational risks including, but not limited to, long lead times, consistent local labor availability and capacity, and timely availability of sufficient shipping carrier capacity, labor and energy on cost of goods sold and certain operating expenses, the geographic concentration and peak season capacity of certain U.S. distribution facilities increases our exposure to significant shipping disruptions and added shipping and storage costs, our projections of product demand, sales and net income are highly subjective in nature and future sales and net income could vary in a material amount from such projections, the risks associated with the use of trademarks licensed from and to third parties, our ability to develop and introduce a continuing stream of new products to meet changing consumer preferences, trade barriers, exchange controls, expropriations, and other risks associated with U.S. and foreign operations, the risks associated with significant tariffs or other restrictions on imports from China or any retaliatory trade measures taken by China, the risks to our liquidity as a result of changes to capital market conditions and other constraints or events that impose constraints on our cash resources and ability to operate our business, the costs, complexity and challenges of upgrading and managing our global information systems, the risks associated with information security breaches, the risks associated with product recalls, product liability, other claims, and related litigation against us, the risks associated with accounting for tax positions, tax audits and related disputes with taxing authorities, the risks of potential changes in laws in the U.S. or abroad, including tax laws, regulations or treaties, employment and health insurance laws and regulations, and laws relating to environmental policy, personal data, financial regulation, transportation policy and infrastructure policy along with the costs and complexities of compliance with such laws, and our ability to continue to avoid classification as a controlled foreign corporation. We undertake no obligation to publicly update or revise any forward-looking statements as a result of new information, future events or otherwise.
Investor Contact:
Helen of Troy Limited
Anne Rakunas, Director,  External Communications
(915) 225-4841
 
ICR, Inc.
Allison Malkin, Partner
(203) 682-8200

7




HELEN OF TROY LIMITED AND SUBSIDIARIES
Condensed Consolidated Statements of Income
(Unaudited)
(in thousands, except per share data) 
 
Three Months Ended November 30,
 
2018
 
2017
Sales revenue, net (9)
$
431,081

 
100.0
 %
 
$
420,841

 
100.0
 %
Cost of goods sold
249,236

 
57.8
 %
 
242,703

 
57.7
 %
Gross profit
181,845

 
42.2
 %
 
178,138

 
42.3
 %
Selling, general and administrative expense ("SG&A") (9)
120,524

 
28.0
 %
 
109,633

 
26.1
 %
Asset impairment charges (8)

 
 %
 

 
 %
Restructuring charges (3)
25

 
 %
 
1,165

 
0.3
 %
Operating income
61,296


14.2
 %

67,340


16.0
 %
Nonoperating income, net
15

 
 %
 
34

 
 %
Interest expense
(2,971
)
 
(0.7
)%
 
(3,505
)
 
(0.8
)%
Income before income tax
58,340

 
13.5
 %
 
63,869

 
15.2
 %
Income tax expense
4,020

 
0.9
 %
 
5,245

 
1.2
 %
Income from continuing operations
54,320

 
12.6
 %
 
58,624

 
13.9
 %
Loss from discontinued operations, net of tax
(4,850
)
 
(1.1
)%
 
(89,060
)
 
(21.2
)%
Net income
$
49,470

 
11.5
 %
 
$
(30,436
)
 
(7.2
)%
Earnings (loss) per share - diluted:
 

 
 

 
 

 
 

Continuing operations
$
2.06

 
 

 
$
2.15

 
 

Discontinued operations
(0.18
)
 
 

 
(3.27
)
 
 

Total earnings per share - diluted
$
1.88

 
 

 
$
(1.12
)
 
 

 
 
 
 
 
 
 
 
Weighted average shares of common stock used in computing diluted earnings per share
26,366

 
 

 
27,267

 
 


 
Nine Months Ended November 30,
 
2018
 
2017
Sales revenue, net (9)
$
1,179,308

 
100.0
 %
 
$
1,091,281

 
100.0
 %
Cost of goods sold
695,732

 
59.0
 %
 
638,096

 
58.5
 %
Gross profit
483,576

 
41.0
 %
 
453,185

 
41.5
 %
SG&A (9)
325,684

 
27.6
 %
 
310,390

 
28.4
 %
Asset impairment charges (8)

 
 %
 
4,000

 
0.4
 %
Restructuring charges (3)
2,609

 
0.2
 %
 
1,165

 
0.1
 %
Operating income
155,283

 
13.2
 %
 
137,630

 
12.6
 %
Nonoperating income, net
175

 
 %
 
281

 
 %
Interest expense
(8,413
)
 
(0.7
)%
 
(10,984
)
 
(1.0
)%
Income before income tax
147,045

 
12.5
 %
 
126,927

 
11.6
 %
Income tax expense
10,535

 
0.9
 %
 
6,423

 
0.6
 %
Income from continuing operations
136,510

 
11.6
 %
 
120,504

 
11.0
 %
Loss from discontinued operations, net of tax
(5,231
)
 
(0.4
)%
 
(136,139
)
 
(12.5
)%
Net income
$
131,279

 
11.1
 %
 
$
(15,635
)
 
(1.4
)%
Earnings (loss) per share - diluted:
 

 
 

 
 

 
 

Continuing operations
$
5.15

 
 

 
$
4.41

 
 

Discontinued operations
(0.20
)
 
 

 
(4.99
)
 
 

Total earnings per share - diluted
$
4.95

 
 

 
$
(0.57
)
 
 

 
 
 
 
 
 
 
 
Weighted average shares of common stock used in computing diluted earnings per share
26,520

 
 

 
27,304

 
 



8



Condensed Consolidated Statements of Income and Reconciliation of Non-GAAP Financial Measures – Adjusted Operating Income, Adjusted Income from Continuing Operations and Adjusted Diluted Earnings Per Share (“EPS”) from Continuing Operations (1)
(Unaudited)
(in thousands, except per share data)
 
Three Months Ended November 30, 2018
 
As Reported
(GAAP)
 
Adjustments
 
Adjusted
(Non-GAAP)
Sales revenue, net (9)
$
431,081

 
100.0
 %
 
$

 
$
431,081

 
100.0
 %
Cost of goods sold
249,236

 
57.8
 %
 

 
249,236

 
57.8
 %
Gross profit
181,845

 
42.2
 %
 

 
181,845

 
42.2
 %
SG&A (9)
120,524

 
28.0
 %
 
(3,300
)
(4)
111,208

 
25.8
 %
 
 

 
 

 
(6,016
)
(5)
 

 
 

Asset impairment charges (8)

 
 %
 

 

 
 %
Restructuring charges (3)
25

 
 %
 
(25
)
(3)

 
 %
Operating income
61,296

 
14.2
 %
 
9,341

 
70,637

 
16.4
 %
Nonoperating income, net
15

 
 %
 

 
15

 
 %
Interest expense
(2,971
)
 
(0.7
)%
 

 
(2,971
)
 
(0.7
)%
Income before income tax
58,340

 
13.5
 %
 
9,341

 
67,681

 
15.7
 %
Income tax expense
4,020

 
0.9
 %
 
463

 
4,483

 
1.0
 %
Income from continuing operations
54,320

 
12.6
 %
 
8,878

 
63,198

 
14.7
 %
Diluted EPS from continuing operations
$
2.06

 
 

 
$
0.34

 
$
2.40

 
 

Weighted average shares of common stock used in computing diluted EPS
26,366

 
 

 
 

 
26,366

 
 


 
Three Months Ended November 30, 2017
 
As Reported
(GAAP)
 
Adjustments
 
Adjusted
(Non-GAAP)
Sales revenue, net (9)
$
420,841

 
100.0
 %
 
$

 
$
420,841

 
100.0
 %
Cost of goods sold
242,703

 
57.7
 %
 

 
242,703

 
57.7
 %
Gross profit
178,138

 
42.3
 %
 

 
178,138

 
42.3
 %
SG&A (9)
109,633

 
26.1
 %
 
(4,660
)
(4)
100,584

 
23.9
 %
 
 

 
 

 
(4,389
)
(5)
 

 
 

 
 
 
 
 
 
 
 
 
 
Asset impairment charges (8)

 
 %
 

 

 
 %
Restructuring charges (3)
1,165

 
0.3
 %
 
(1,165
)
(3)

 
 %
Operating income
67,340

 
16.0
 %
 
10,214

 
77,554

 
18.4
 %
Nonoperating income, net
34

 
 %
 

 
34

 
 %
Interest expense
(3,505
)
 
(0.8
)%
 

 
(3,505
)
 
(0.8
)%
Income before income tax
63,869

 
15.2
 %
 
10,214

 
74,083

 
17.6
 %
Income tax expense
5,245

 
1.2
 %
 
777

 
6,022

 
1.4
 %
Income from continuing operations
58,624

 
13.9
 %
 
9,437

 
68,061

 
16.2
 %
Diluted EPS from continuing operations
$
2.15

 
 

 
$
0.35

 
$
2.50

 
 

Weighted average shares of common stock used in computing diluted EPS
27,267

 
 

 
 

 
27,267

 
 















9




Condensed Consolidated Statements of Income and Reconciliation of Non-GAAP Financial Measures – Adjusted Operating Income, Adjusted Income from Continuing Operations and Adjusted Diluted Earnings Per Share (“EPS”) from Continuing Operations (1)
(Unaudited)
(in thousands, except per share data)
 
Nine Months Ended November 30, 2018
 
As Reported
(GAAP)
 
Adjustments
 
Adjusted
(Non-GAAP)
Sales revenue, net (9)
$
1,179,308

 
100.0
 %
 
$

 
$
1,179,308

 
100.0
 %
Cost of goods sold
695,732

 
59.0
 %
 

 
695,732

 
59.0
 %
Gross profit
483,576

 
41.0
 %
 

 
483,576

 
41.0
 %
SG&A (9)
325,684

 
27.6
 %
 
(10,822
)
(4)
297,833

 
25.3
 %
 
 

 
 

 
(17,029
)
(5)
 

 
 

Asset impairment charges (8)

 
 %
 

 

 
 %
Restructuring charges (3)
2,609

 
0.2
 %
 
(2,609
)
(3)

 
 %
Operating income
155,283

 
13.2
 %
 
30,460

 
185,743

 
15.8
 %
Nonoperating income, net
175

 
 %
 

 
175

 
 %
Interest expense
(8,413
)
 
(0.7
)%
 

 
(8,413
)
 
(0.7
)%
Income before income tax
147,045

 
12.5
 %
 
30,460

 
177,505

 
15.1
 %
Income tax expense
10,535

 
0.9
 %
 
1,442

 
11,977

 
1.0
 %
Income from continuing operations
136,510

 
11.6
 %
 
29,018

 
165,528

 
14.0
 %
Diluted EPS from continuing operations
$
5.15

 
 

 
$
1.09

 
$
6.24

 
 

Weighted average shares of common stock used in computing diluted EPS
26,520

 
 

 
 

 
26,520

 
 


 
Nine Months Ended November 30, 2017
 
As Reported
(GAAP)
 
Adjustments
 
Adjusted
(Non-GAAP)
Sales revenue, net (9)
$
1,091,281

 
100.0
 %
 
$

 
$
1,091,281

 
100.0
 %
Cost of goods sold
638,096

 
58.5
 %
 

 
638,096

 
58.5
 %
Gross profit
453,185

 
41.5
 %
 

 
453,185

 
41.5
 %
SG&A (9)
310,390

 
28.4
 %
 
(14,198
)
(4)
281,977

 
25.8
 %
 
 

 
 

 
(10,619
)
(5)
 

 
 

 
 
 
 
 
(3,596
)
(7)
 
 
 
Asset impairment charges (8)
4,000

 
0.4
 %
 
(4,000
)
(8)

 
 %
Restructuring charges (3)
1,165

 
0.1
 %
 
(1,165
)
(3)

 
 %
Operating income
137,630

 
12.6
 %
 
33,578

 
171,208

 
15.7
 %
Nonoperating income, net
281

 
 %
 

 
281

 
 %
Interest expense
(10,984
)
 
(1.0
)%
 

 
(10,984
)
 
(1.0
)%
Income before income tax
126,927

 
11.6
 %
 
33,578

 
160,505

 
14.7
 %
Income tax expense
6,423

 
0.6
 %
 
2,526

 
8,949

 
0.8
 %
Income from continuing operations
120,504

 
11.0
 %
 
31,052

 
151,556

 
13.9
 %
Diluted EPS from continuing operations
$
4.41

 
 

 
$
1.14

 
$
5.55

 
 

Weighted average shares of common stock used in computing diluted EPS
27,304

 
 

 
 

 
27,304

 
 



10



Consolidated and Segment Net Sales, Operating Margin and Adjusted Operating Margin (non-GAAP) (1)
(Unaudited)
(in thousands)
 
Three Months Ended November 30,
 
Housewares
 
Health & Home
 
Beauty
 
Total
Fiscal 2018 sales revenue, net
$
128,261

 
$
189,240

 
$
103,340

 
$
420,841

Core business growth (decline)
14,828

 
(313
)
 
(2,458
)
 
12,057

Impact of foreign currency
(152
)
 
(1,064
)
 
(601
)
 
(1,817
)
Change in sales revenue, net
14,676

 
(1,377
)
 
(3,059
)
 
10,240

Fiscal 2019 sales revenue, net
$
142,937

 
$
187,863

 
$
100,281

 
$
431,081

Total net sales revenue growth (decline)
11.4
 %
 
(0.7
)%
 
(3.0
)%
 
2.4
 %
Core business growth (decline)
11.6
 %
 
(0.2
)%
 
(2.4
)%
 
2.9
 %
Impact of foreign currency
(0.1
)%
 
(0.6
)%
 
(0.6
)%
 
(0.4
)%
Operating margin (GAAP)
 
 
 
 
 
 
 
Fiscal 2019
20.9
 %
 
10.2
 %
 
12.2
 %
 
14.2
 %
Fiscal 2018
23.2
 %
 
14.6
 %
 
9.6
 %
 
16.0
 %
Adjusted operating margin (non-GAAP)
 
 
 
 
 
 
 
Fiscal 2019
22.8
 %
 
13.0
 %
 
13.5
 %
 
16.4
 %
Fiscal 2018
24.7
 %
 
17.0
 %
 
13.3
 %
 
18.4
 %

 
Nine Months Ended November 30,
 
Housewares
 
Health & Home
 
Beauty
 
Total
Fiscal 2018 sales revenue, net
$
342,050

 
$
483,592

 
$
265,639

 
$
1,091,281

Core business growth (decline)
55,414

 
41,658

 
(10,432
)
 
86,640

Impact of foreign currency
274

 
1,827

 
(714
)
 
1,387

Change in sales revenue, net
55,688

 
43,485

 
(11,146
)
 
88,027

Fiscal 2019 sales revenue, net
$
397,738

 
$
527,077

 
$
254,493

 
$
1,179,308

Total net sales revenue growth (decline)
16.3
%
 
9.0
%
 
(4.2
)%
 
8.1
%
Core business growth (decline)
16.2
%
 
8.6
%
 
(3.9
)%
 
7.9
%
Impact of foreign currency
0.1
%
 
0.4
%
 
(0.3
)%
 
0.1
%
Operating margin (GAAP)
 
 
 
 
 
 
 
Fiscal 2019
20.2
%
 
10.0
%
 
8.8
 %
 
13.2
%
Fiscal 2018
20.8
%
 
10.2
%
 
6.5
 %
 
12.6
%
Adjusted operating margin (non-GAAP)
 
 
 
 
 
 
 
Fiscal 2019
22.3
%
 
12.9
%
 
11.4
 %
 
15.8
%
Fiscal 2018
22.5
%
 
13.3
%
 
11.3
 %
 
15.7
%

Leadership Brand Net Sales Revenue (1) (2)
(Unaudited)
(in thousands)
 
Three Months Ended November 30,
 
Nine Months Ended November 30,
 
2018
 
2017
 
2018
 
2017
Leadership Brand sales revenue, net
$
343,364

 
$
327,288

 
$
943,168

 
$
836,993

All other sales revenue, net
87,717

 
93,553

 
236,140

 
254,288

Total sales revenue, net
$
431,081

 
$
420,841

 
$
1,179,308

 
$
1,091,281



11



SELECTED OTHER DATA
Reconciliation of Non-GAAP Financial Measures – GAAP Operating Income
to Adjusted Operating Income (non-GAAP) (1)
(Unaudited)
(in thousands) 
 
Three Months Ended November 30, 2018
 
Housewares
 
Health & Home
 
Beauty
 
Total
Operating income, as reported (GAAP)
$
29,839

 
20.9
%
 
$
19,213

 
10.2
%
 
$
12,244

 
12.2
%
 
$
61,296

 
14.2
%
Restructuring charges (3)
(20
)
 

 

 

 
45

 
%
 
25

 
%
Subtotal
29,819

 
20.9
%
 
19,213

 
10.2
%
 
12,289

 
12.3
%
 
61,321

 
14.2
%
Amortization of intangible assets
489

 
0.3
%
 
2,721

 
1.4
%
 
90

 
0.1
%
 
3,300

 
0.8
%
Non-cash share-based compensation
2,293

 
1.6
%
 
2,548

 
1.4
%
 
1,175

 
1.2
%
 
6,016

 
1.4
%
Adjusted operating income (non-GAAP)
$
32,601

 
22.8
%
 
$
24,482

 
13.0
%
 
$
13,554

 
13.5
%
 
$
70,637

 
16.4
%
 
 
Three Months Ended November 30, 2017
 
Housewares
 
Health & Home
 
Beauty
 
Total
Operating income, as reported (GAAP)
$
29,809

 
23.2
%
 
$
27,584

 
14.6
%
 
$
9,947

 
9.6
%
 
$
67,340

 
16.0
%
Asset impairment charges (8)

 
%
 

 
%
 

 
%
 

 
%
Restructuring charges (3)

 
%
 

 
%
 
1,165

 
1.1
%
 
1,165

 
0.3
%
Subtotal
29,809

 
23.2
%
 
27,584

 
14.6
%
 
11,112

 
10.8
%
 
68,505

 
16.3
%
Amortization of intangible assets
489

 
0.4
%
 
2,797

 
1.5
%
 
1,374

 
1.3
%
 
4,660

 
1.1
%
Non-cash share-based compensation
1,439

 
1.1
%
 
1,711

 
0.9
%
 
1,239

 
1.2
%
 
4,389

 
1.0
%
Adjusted operating income (non-GAAP)
$
31,737

 
24.7
%
 
$
32,092

 
17.0
%
 
$
13,725

 
13.3
%
 
$
77,554

 
18.4
%
 
Nine Months Ended November 30, 2018
 
Housewares
 
Health & Home
 
Beauty
 
Total
Operating income, as reported (GAAP)
$
80,351

 
20.2
%
 
$
52,501

 
10.0
%
 
$
22,431

 
8.8
%
 
$
155,283

 
13.2
%
Restructuring charges (3)
740

 
0.2
%
 
358

 
0.1
%
 
1,511

 
0.6
%
 
2,609

 
0.2
%
Subtotal
81,091

 
20.4
%
 
52,859

 
10.0
%
 
23,942

 
9.4
%
 
157,892

 
13.4
%
Amortization of intangible assets
1,474

 
0.4
%
 
8,129

 
1.5
%
 
1,219

 
0.5
%
 
10,822

 
0.9
%
Non-cash share-based compensation
6,273

 
1.6
%
 
7,030

 
1.3
%
 
3,726

 
1.5
%
 
17,029

 
1.4
%
Adjusted operating income (non-GAAP)
$
88,838

 
22.3
%
 
$
68,018

 
12.9
%
 
$
28,887

 
11.4
%
 
$
185,743

 
15.8
%
 
Nine Months Ended November 30, 2017
 
Housewares
 
Health & Home
 
Beauty
 
Total
Operating income, as reported (GAAP)
$
71,085

 
20.8
%
 
$
49,243

 
10.2
%
 
$
17,302

 
6.5
%
 
$
137,630

 
12.6
%
Asset impairment charges (8)

 

 

 

 
4,000

 
1.5
%
 
4,000

 
0.4
%
TRU bankruptcy charge (7)
956

 
0.3
%
 
2,640

 
0.5
%
 

 

 
3,596

 
0.3
%
Restructuring charges (3)

 
%
 

 
%
 
1,165

 
0.4
%
 
1,165

 
0.1
%
Subtotal
72,041

 
21.1
%
 
51,883

 
10.7
%
 
22,467

 
8.5
%
 
146,391

 
13.4
%
Amortization of intangible assets
1,618

 
0.5
%
 
8,373

 
1.7
%
 
4,207

 
1.6
%
 
14,198

 
1.3
%
Non-cash share-based compensation
3,380

 
1.0
%
 
3,971

 
0.8
%
 
3,268

 
1.2
%
 
10,619

 
1.0
%
Adjusted operating income (non-GAAP)
$
77,039

 
22.5
%
 
$
64,227

 
13.3
%
 
$
29,942

 
11.3
%
 
$
171,208

 
15.7
%


12



SELECTED OTHER DATA
Reconciliation of Non-GAAP Financial Measures - EBITDA
(Earnings Before Interest, Taxes, Depreciation and Amortization) and Adjusted EBITDA by Segment (1)
(Unaudited)
(in thousands) 
 
Three Months Ended November 30, 2018
 
Housewares
 
Health & Home
 
Beauty
 
Total
Operating income, as reported (GAAP)
$
29,839

 
$
19,213

 
$
12,244

 
$
61,296

Depreciation and amortization, excluding amortized interest
1,408

 
4,326

 
1,461

 
7,195

Nonoperating income, net

 

 
15

 
15

EBITDA (non-GAAP)
31,247

 
23,539

 
13,720

 
68,506

  Add: Restructuring charges (3)
(20
)
 

 
45

 
25

   Non-cash share-based compensation
2,293

 
2,548

 
1,175

 
6,016

Adjusted EBITDA (non-GAAP)
$
33,520

 
$
26,087

 
$
14,940

 
$
74,547

 
Three Months Ended November 30, 2017
 
Housewares
 
Health & Home
 
Beauty
 
Total
Operating income, as reported (GAAP)
$
29,809

 
$
27,584

 
$
9,947

 
$
67,340

Depreciation and amortization, excluding amortized interest
1,444

 
4,232

 
2,707

 
8,383

Nonoperating income, net

 

 
34

 
34

EBITDA (non-GAAP)
31,253

 
31,816

 
12,688

 
75,757

Add: Restructuring charges (3)

 

 
1,165

 
1,165

 Non-cash share-based compensation
1,439

 
1,711

 
1,239

 
4,389

Adjusted EBITDA (non-GAAP)
$
32,692

 
$
33,527

 
$
15,092

 
$
81,311

 
Nine Months Ended November 30, 2018
 
Housewares
 
Health & Home
 
Beauty
 
Total
Operating income, as reported (GAAP)
$
80,351

 
$
52,501

 
$
22,431

 
$
155,283

Depreciation and amortization, excluding amortized interest
4,414

 
12,703

 
5,373

 
22,490

Nonoperating income, net

 

 
175

 
175

EBITDA (non-GAAP)
84,765

 
65,204

 
27,979

 
177,948

  Add: Restructuring charges (3)
740

 
358

 
1,511

 
2,609

   Non-cash share-based compensation
6,273

 
7,030

 
3,726

 
17,029

Adjusted EBITDA (non-GAAP)
$
91,778

 
$
72,592

 
$
33,216

 
$
197,586

 
Nine Months Ended November 30, 2017
 
Housewares
 
Health & Home
 
Beauty
 
Total
Operating income, as reported (GAAP)
$
71,085

 
$
49,243

 
$
17,302

 
$
137,630

Depreciation and amortization, excluding amortized interest
4,290

 
12,553

 
8,296

 
25,139

Nonoperating income, net

 

 
281

 
281

EBITDA (non-GAAP)
75,375

 
61,796

 
25,879

 
163,050

Add: TRU bankruptcy charge (7)
956

 
2,640

 

 
3,596

 Non-cash asset impairment charges

 

 
4,000

 
4,000

 Restructuring charges (3)

 

 
1,165

 
1,165

 Non-cash share-based compensation
3,380

 
3,971

 
3,268

 
10,619

Adjusted EBITDA (non-GAAP)
$
79,711

 
$
68,407

 
$
34,312

 
$
182,430



13




Reconciliation of GAAP Income and Diluted Earnings Per Share  (“EPS”) from Continuing Operations to Adjusted Income and Adjusted Diluted EPS from Continuing Operations (non-GAAP) (1)(Unaudited)
(dollars in thousands, except per share data) 
 
Three Months Ended November 30, 2018
 
Income from Continuing Operations
 
Diluted EPS
 
Before Tax
 
Tax
 
Net of Tax
 
Before Tax
 
Tax
 
Net of Tax
As reported (GAAP)
$
58,340

 
$
4,020

 
$
54,320

 
$
2.21

 
$
0.15

 
$
2.06

Restructuring charges (3)
25

 
2

 
23

 

 

 

Subtotal
58,365

 
4,022

 
54,343

 
2.21

 
0.15

 
2.06

Amortization of intangible assets
3,300

 
46

 
3,254

 
0.13

 

 
0.12

Non-cash share-based compensation
6,016

 
415

 
5,601

 
0.23

 
0.02

 
0.21

Adjusted (non-GAAP)
$
67,681

 
$
4,483

 
$
63,198

 
$
2.57

 
$
0.17

 
$
2.40

 
 
 
 
 
 
 
 
 
 
 
 
Weighted average shares of common stock used in computing diluted EPS
 
26,366

 
Three Months Ended November 30, 2017
 
Income from Continuing Operations
 
Diluted EPS
 
Before Tax
 
Tax
 
Net of Tax
 
Before Tax
 
Tax
 
Net of Tax
As reported (GAAP)
$
63,869

 
$
5,245

 
$
58,624

 
$
2.34

 
$
0.19

 
$
2.15

Asset impairment charges

 

 

 

 

 

Restructuring charges (3)
1,165

 
68

 
1,097

 
0.04

 

 
0.04

Subtotal
65,034

 
5,313

 
59,721

 
2.39

 
0.19

 
2.19

Amortization of intangible assets
4,660

 
211

 
4,449

 
0.17

 
0.01

 
0.16

Non-cash share-based compensation
4,389

 
498

 
3,891

 
0.16

 
0.02

 
0.14

Adjusted (non-GAAP)
$
74,083

 
$
6,022

 
$
68,061

 
$
2.72

 
$
0.22

 
$
2.50

 
 
 
 
 
 
 
 
 
 
 
 
Weighted average shares of common stock used in computing diluted EPS
 
27,267

 
Nine Months Ended November 30, 2018
 
Income from Continuing Operations
 
Diluted EPS
 
Before Tax
 
Tax
 
Net of Tax
 
Before Tax
 
Tax
 
Net of Tax
As reported (GAAP)
$
147,045

 
$
10,535

 
$
136,510

 
$
5.54

 
$
0.40

 
$
5.15

Restructuring charges (3)
2,609

 
185

 
2,424

 
0.10

 
0.01

 
0.09

Subtotal
149,654

 
10,720

 
138,934

 
5.64

 
0.40

 
5.24

Amortization of intangible assets
10,822

 
236

 
10,586

 
0.41

 
0.01

 
0.40

Non-cash share-based compensation
17,029

 
1,021

 
16,008

 
0.64

 
0.04

 
0.60

Adjusted (non-GAAP)
$
177,505

 
$
11,977

 
$
165,528

 
$
6.69

 
$
0.45

 
$
6.24

 
 
 
 
 
 
 
 
 
 
 
 
Weighted average shares of common stock used in computing diluted EPS
 
26,520

 
Nine Months Ended November 30, 2017
 
Income from Continuing Operations
 
Diluted EPS
 
Before Tax
 
Tax
 
Net of Tax
 
Before Tax
 
Tax
 
Net of Tax
As reported (GAAP)
$
126,927

 
$
6,423

 
$
120,504

 
$
4.65

 
$
0.24

 
$
4.41

Asset impairment charges
4,000

 
418

 
3,582

 
0.15

 
0.02

 
0.13

TRU bankruptcy charge (7)
3,596

 
204

 
3,392

 
0.13

 
0.01

 
0.12

Restructuring charges (3)
1,165

 
68

 
1,097

 
0.04

 

 
0.04

Subtotal
135,688

 
7,113

 
128,575

 
4.97

 
0.26

 
4.71

Amortization of intangible assets
14,198

 
658

 
13,540

 
0.52

 
0.02

 
0.50

Non-cash share-based compensation
10,619

 
1,178

 
9,441

 
0.39

 
0.04

 
0.35

Adjusted (non-GAAP)
$
160,505

 
$
8,949

 
$
151,556

 
$
5.88

 
$
0.33

 
$
5.55

 
 
 
 
 
 
 
 
 
 
 
 
Weighted average shares of common stock used in computing diluted EPS
 
27,304


14



Selected Consolidated Balance Sheet, Cash Flow and Liquidity Information (6)
(Unaudited)
(in thousands)
 
November 30,
 
2018
 
2017
Balance Sheet:
 

 
 

Cash and cash equivalents
$
19,136

 
$
19,925

Receivables, net
339,124

 
306,683

Inventory, net
300,648

 
278,082

Total assets, current
673,345

 
616,671

Total assets
1,725,369

 
1,710,083

Total liabilities, current
335,337

 
353,134

Total long-term liabilities
356,774

 
427,398

Total debt
339,730

 
426,191

Consolidated stockholders' equity
1,033,258

 
984,409

Liquidity:
 
 
 
Working capital
$
338,008

 
$
263,537

 
Nine Months Ended November 30,
 
2018
 
2017
Cash Flow from continuing operations:
 
 
 
Depreciation and amortization
$
22,490

 
$
25,139

Net cash provided by operating activities
109,495

 
102,913

Capital and intangible asset expenditures
22,166

 
10,375

Net debt proceeds (repayments)
49,100

 
(60,400
)
Payments for repurchases of common stock
137,067

 
29,158



15



Fiscal 2019 Updated Outlook for Net Sales Revenue After Adoption of Revenue Recognition Standard
(Unaudited)
(in thousands)  
 
Fiscal 2018
 
Updated Outlook for Fiscal 2019
Net sales revenue prior to adoption
$
1,489,747

 
$
1,548,000

 
 
$
1,563,000

Reclassification of expense from SG&A to net sales revenue
(10,901
)
 
(13,000
)
 
 
(13,000
)
Expected net sales revenue after adoption
$
1,478,846

 
$
1,535,000

 
 
$
1,550,000

 
 
 
 
 
 
 
 
Fiscal 2019 net sales revenue growth after adoption
 
 
3.8
%
 
 
4.8
%
 
Reconciliation of Fiscal 2019 Updated Outlook for GAAP Diluted Earnings Per Share (“EPS”) from Continuing Operations to Adjusted Diluted EPS from Continuing Operations (non-GAAP) (1)  (Unaudited)  
 
Nine Months Ended November 30, 2018
 
Outlook for the
Balance of the
Fiscal Year
(Three Months)
 
Updated Outlook Fiscal 2019
Diluted EPS from continuing operations, as reported (GAAP)
$
5.15

 
$
1.20

 
 
$
1.36

 
$
6.35

 
 
$
6.51

Restructuring charges, net of tax
0.09

 
0.01

 
 
0.04

 
0.10

 
 
0.13

Subtotal
5.24

 
1.21

 
 
1.40

 
6.45

 
 
6.64

Amortization of intangible assets, net of tax
0.40

 
0.12

 
 
0.13

 
0.52

 
 
0.53

Non-cash share-based compensation, net of tax
0.60

 
0.13

 
 
0.18

 
0.73

 
 
0.78

Adjusted diluted EPS from continuing operations (non-GAAP)
$
6.24

 
$
1.46

 
 
$
1.71

 
$
7.70

 
 
$
7.95


Effective Tax Rate (GAAP) and Adjusted Effective Tax Rate (Non-GAAP) (1)
(Unaudited) 
 
 
Nine Months Ended November 30, 2018
 
Outlook for the
Balance of the
Fiscal Year
(Three Months)
 
Updated Outlook Fiscal 2019
Effective tax rate, as reported (GAAP)
7.2
 %
 
7.9
 %
 
 
12.0
 %
 
7.3
 %
 
 
8.4
 %
Restructuring charges
 %
 
 %
 
 
 %
 
 %
 
 
 %
Subtotal
7.2
 %

7.9
 %


12.0
 %

7.3
 %


8.4
 %
Amortization of intangible assets
(0.3
)%
 
(0.4
)%
 
 
(0.7
)%
 
(0.4
)%
 
 
(0.4
)%
Non-cash share based compensation
(0.1
)%
 
(0.2
)%
 
 
(0.5
)%
 
(0.1
)%
 
 
(0.2
)%
Adjusted effective tax rate
6.7
 %

7.3
 %


10.8
 %

6.9
 %


7.7
 %

16



HELEN OF TROY LIMITED AND SUBSIDIARIES
Notes to Press Release
(1)
This press release contains non-GAAP financial measures. Leadership Brand net sales revenue, adjusted operating income, adjusted operating margin, adjusted effective tax rate, adjusted income, adjusted diluted EPS, EBITDA, and adjusted EBITDA (“Non-GAAP measures”) that are discussed in the accompanying press release or in the preceding tables may be considered non-GAAP financial information as contemplated by SEC Regulation G, Rule 100. Accordingly, we are providing the preceding tables that reconcile these measures to their corresponding GAAP-based measures presented in our Condensed Consolidated Statements of Income in the accompanying tables to the press release. The Company believes that these non-GAAP measures provide useful information to management and investors regarding financial and business trends relating to its financial condition and results of operations. We believe that these non-GAAP financial measures, in combination with the Company’s financial results calculated in accordance with GAAP, provide investors with additional perspective regarding the impact of certain charges on net income and earnings per share. We also believe that these non-GAAP measures facilitate a more direct comparison of the Company’s performance with its competitors. We further believe that including the excluded charges would not accurately reflect the underlying performance of the Company’s continuing operations for the period in which the charges are incurred, even though such charges may be incurred and reflected in the Company’s GAAP financial results in the near future. Additionally, the non-GAAP measures are used by management for measuring and evaluating the Company’s performance. The material limitation associated with the use of the non-GAAP measures is that the non-GAAP measures do not reflect the full economic impact of the Company’s activities. These non-GAAP measures are not prepared in accordance with GAAP, are not an alternative to GAAP financial information, and may be calculated differently than non-GAAP financial information disclosed by other companies. Accordingly, undue reliance should not be placed on non-GAAP information.
(2)
Leadership Brand net sales consists of revenue from the OXO, Honeywell, Braun, PUR, Hydro Flask, Vicks and Hot Tools brands.
(3)
Charges incurred in conjunction with the Company’s restructuring plan (Project Refuel) for the three and nine months ended November 30, 2018 and 2017.
(4)
Amortization of intangible assets.
(5)
Non-cash share-based compensation.
(6)
Amounts presented are from continuing operations with the exception of stockholders’ equity, which is presented on a consolidated basis and includes discontinued operations. 
(7)
A $3.6 million charge ($3.4 million after tax) related to the Toys “R” Us, Inc. (“TRU”) bankruptcy for the nine months ended November 30, 2017.
(8)
During the nine months ended November 30, 2017, we recorded a pre-tax non-cash asset impairment charge of $4.0 million in our Beauty segment.
(9)
We adopted ASU 2014-09 in the first quarter of fiscal 2019 and have reclassified amounts in the prior year’s statement of income to conform to the current period’s presentation, as follows: 
 
Before Reclassification
 
 
 
After Reclassification
Statement of Income (in thousands)
Three Months Ended November 30, 2017
 
Reclassification
 
Three Months Ended November 30, 2017
Sales revenue, net
$
423,709

 
$
(2,868
)
 
$
420,841

SG&A
$
112,501

 
$
(2,868
)
 
$
109,633


 
Before Reclassification
 
 
 
After Reclassification
Statement of Income (in thousands)
Nine Months Ended November 30, 2017
 
Reclassification
 
Nine Months Ended November 30, 2017
Sales revenue, net 
$
1,098,900

 
$
(7,619
)
 
$
1,091,281

SG&A 
$
318,009

 
$
(7,619
)
 
$
310,390



17